Life Sciences Tools & Services Companies By Ps Ratio

Price To Sales
Price To SalesEfficiencyMarket RiskExp Return
1TEM Tempus AI, Class
14.06
 0.12 
 8.33 
 1.03 
2RGEN Repligen
11.81
(0.02)
 3.17 
(0.07)
3TECH Bio Techne Corp
7.76
(0.14)
 2.18 
(0.31)
4SEER Seer Inc
7.34
(0.21)
 2.02 
(0.41)
5WAT Waters
7.27
 0.01 
 1.82 
 0.01 
6MTD Mettler Toledo International
6.42
(0.01)
 1.59 
(0.02)
7ADPT Adaptive Biotechnologies Corp
6.37
 0.12 
 5.18 
 0.61 
8CGEN Compugen
5.19
 0.03 
 4.80 
 0.13 
9A Agilent Technologies
5.09
(0.13)
 1.64 
(0.22)
10RVTY Revvity
4.61
(0.03)
 2.01 
(0.07)
11MEDP Medpace Holdings
4.51
(0.03)
 1.98 
(0.06)
12TMO Thermo Fisher Scientific
4.4
(0.01)
 1.54 
(0.01)
13QGEN Qiagen NV
4.35
(0.12)
 1.51 
(0.18)
14CDXS Codexis
3.92
(0.11)
 5.66 
(0.61)
15PSNL Personalis
3.78
(0.11)
 5.93 
(0.64)
16SHC Sotera Health Co
3.03
(0.08)
 2.20 
(0.18)
17ILMN Illumina
2.9
(0.28)
 2.73 
(0.75)
18MLAB Mesa Laboratories
2.73
(0.02)
 2.87 
(0.05)
19BIO-B Bio Rad Laboratories
2.7
(0.24)
 4.12 
(0.98)
20BIO Bio Rad Laboratories
2.69
(0.19)
 2.36 
(0.45)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries. The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.